Longitudinal CT-derived muscle-fat-bone remodeling following androgen deprivation therapy initiation in prostate cancer.
4 affiliations
- 1Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Foggia, Italy.
- 2Radiology Unit, "V. Emanuele II" Hospital, Bisceglie, Italy.
- 3Radiology Unit, "A. Perrino" Hospital, Brindisi, Italy.
- 4Radiology Unit, "M. Dimiccoli" Hospital, Barletta, Italy.
Abstract
Introduction
Androgen deprivation therapy (ADT) is a cornerstone of prostate cancer treatment and is commonly accompanied by longitudinal changes in muscle, adipose tissue, and skeletal health that may be poorly captured by conventional anthropometric measures. This study investigated whether routine oncologic computed tomography (CT) could provide an integrated longitudinal assessment of muscle, adipose tissue, and vertebral trabecular attenuation following ADT initiation.Methods
In this retrospective, single-center longitudinal study, 60 consecutive men with prostate cancer initiating ADT between January 2023 and May 2025 were screened at Antonio Perrino Hospital, Brindisi, Italy, with clinical follow-up available through July 2026. Forty patients with an eligible baseline CT obtained within 30 days before ADT initiation and a technically comparable follow-up CT at 12 ± 2 months were included. At L3, skeletal muscle index (SMI), bilateral psoas attenuation, subcutaneous adipose tissue index (SATI), and visceral adipose tissue index (VATI) were assessed. Trabecular vertebral attenuation was measured at L1-L3.Results
Mean SMI decreased from 48.4 ± 6.9 to 45.5 ± 6.8 cm²/m² (-6.0%; p<0.001), while mean psoas attenuation decreased from 41.0 ± 5.9 to 37.8 ± 6.0 HU (-7.8%; p<0.001). SATI increased by 11.6% (p<0.001), VATI by 6.2% (p=0.018), and mean vertebral trabecular attenuation decreased by 4.4% (p=0.006). BMI changed only modestly and showed a weak relationship with SMI change. Twenty-three patients (57.5%) had an SMI decline ≥5%, a prespecified exploratory threshold. In an exploratory parsimonious adjusted analysis, lower baseline psoas attenuation was associated with subsequent SMI decline ≥5%; however, the limited sample size precludes interpretation as an independent predictive biomarker.Discussion
Routine oncologic CT demonstrated concurrent longitudinal changes in muscle, adipose tissue, and vertebral attenuation following ADT initiation that were only weakly reflected by BMI. These findings support further evaluation of integrated opportunistic CT phenotyping in larger controlled cohorts.
Related
- Fracture and Vertebral Augmentation Utilization Following Androgen Deprivation Therapy in Men With Prostate Cancer: A Propensity Score–matched Cohort Study
- Persistent Post-Burn Pruritus Following Antihistamine Initiation: A Retrospective Longitudinal Study at a Single Italian Pediatric Burn Center
- Comparative outcomes of radical prostatectomy, radiotherapy, and radiotherapy plus androgen deprivation therapy for high-risk and very high-risk prostate cancer: a narrative review
- An Immunocompetent Mouse Model of Degarelix Induced Chemical Castration to Investigate Acquired Resistance to Androgen Deprivation.
- Effects of androgen deprivation therapy on cerebral glucose metabolism in prostate cancer.
BibTeX
@article{montatore2026longitudinal,
title = {{Longitudinal CT-derived muscle-fat-bone remodeling following androgen deprivation therapy initiation in prostate cancer.}},
author = {Manuela Montatore and Gianmichele Muscatella and Federica Masino and Eluisa Muscogiuri and Giuseppe Guglielmi},
journal = {Frontiers in urology},
year = {2026},
month = oct,
doi = {10.3389/fruro.2026.1985221},
url = {https://europepmc.org/article/MED/42923055},
note = {CC BY},
}
RIS
TY - JOUR
TI - Longitudinal CT-derived muscle-fat-bone remodeling following androgen deprivation therapy initiation in prostate cancer.
AU - Manuela Montatore
AU - Gianmichele Muscatella
AU - Federica Masino
AU - Eluisa Muscogiuri
AU - Giuseppe Guglielmi
PY - 2026
DA - 2026/10/08
JO - Frontiers in urology
DO - 10.3389/fruro.2026.1985221
UR - https://europepmc.org/article/MED/42923055
AB - Introduction Androgen deprivation therapy (ADT) is a cornerstone of prostate cancer treatment and is commonly accompanied by longitudinal changes in muscle, adipose tissue, and skeletal health that may be poorly captured by conventional anthropometric measures. This study investigated whether routine oncologic computed tomography (CT) could provide an integrated longitudinal assessment of muscle, adipose tissue, and vertebral trabecular attenuation following ADT initiation.Methods In this retrospective, single-center longitudinal study, 60 consecutive men with prostate cancer initiating ADT between January 2023 and May 2025 were screened at Antonio Perrino Hospital, Brindisi, Italy, with clinical follow-up available through July 2026. Forty patients with an eligible baseline CT obtained within 30 days before ADT initiation and a technically comparable follow-up CT at 12 ± 2 months were included. At L3, skeletal muscle index (SMI), bilateral psoas attenuation, subcutaneous adipose tissue index (SATI), and visceral adipose tissue index (VATI) were assessed. Trabecular vertebral attenuation was measured at L1-L3.Results Mean SMI decreased from 48.4 ± 6.9 to 45.5 ± 6.8 cm²/m² (-6.0%; p<0.001), while mean psoas attenuation decreased from 41.0 ± 5.9 to 37.8 ± 6.0 HU (-7.8%; p<0.001). SATI increased by 11.6% (p<0.001), VATI by 6.2% (p=0.018), and mean vertebral trabecular attenuation decreased by 4.4% (p=0.006). BMI changed only modestly and showed a weak relationship with SMI change. Twenty-three patients (57.5%) had an SMI decline ≥5%, a prespecified exploratory threshold. In an exploratory parsimonious adjusted analysis, lower baseline psoas attenuation was associated with subsequent SMI decline ≥5%; however, the limited sample size precludes interpretation as an independent predictive biomarker.Discussion Routine oncologic CT demonstrated concurrent longitudinal changes in muscle, adipose tissue, and vertebral attenuation following ADT initiation that were only weakly reflected by BMI. These findings support further evaluation of integrated opportunistic CT phenotyping in larger controlled cohorts.
SN - 2673-9828
ER -